Immunophenotypic measurable residual disease (MRD) in acute myeloid leukemia: Is multicentric MRD assessment feasible?
来源期刊:Leukemia researchDOI:10.1016/j.leukres.2018.11.014
Programmed Cell Death Receptor (PD-1) Ligand (PD-L1) expression in Philadelphia chromosome-negative myeloproliferative neoplasms.
来源期刊:Leukemia researchDOI:10.1016/j.leukres.2019.02.010
A phase I study of panobinostat and ruxolitinib in patients with primary myelofibrosis (PMF) and post--polycythemia vera/essential thrombocythemia myelofibrosis (post--PV/ET MF).
来源期刊:Leukemia researchDOI:10.1016/j.leukres.2019.106272
A phase 2 trial of the oral smoothened inhibitor glasdegib in refractory myelodysplastic syndromes (MDS).
来源期刊:Leukemia researchDOI:10.1016/J.LEUKRES.2019.03.008
Identification of a novel, internal tRNA-derived RNA fragment as a new prognostic and screening biomarker in chronic lymphocytic leukemia, using an innovative quantitative real-time PCR assay.
来源期刊:Leukemia researchDOI:10.1016/j.leukres.2019.106234
Prognostic significance of MYC oncoprotein expression on survival outcome in patients with acute myeloid leukemia with myelodysplasia related changes (AML-MRC).
来源期刊:Leukemia researchDOI:10.1016/j.leukres.2019.106194
A precision medicine test predicts clinical response after idarubicin and cytarabine induction therapy in AML patients.
来源期刊:Leukemia researchDOI:10.1016/j.leukres.2018.11.006
A retrospective study evaluating treatment patterns and survival outcomes in elderly patients with acute myeloid leukemia treated in the United States with either 7+3 or a hypomethylating agent.
来源期刊:Leukemia researchDOI:10.1016/j.leukres.2019.01.008
Efficacy outcomes in the treatment of older or medically unfit patients with acute myeloid leukaemia: A systematic review and meta-analysis.
来源期刊:Leukemia researchDOI:10.1016/j.leukres.2019.05.007
Ex vivo resistance in childhood acute lymphoblastic leukemia: Correlations between BCRP, MRP1, MRP4 and MRP5 ABC transporter expression and intracellular methotrexate polyglutamate accumulation.
来源期刊:Leukemia researchDOI:10.1016/j.leukres.2019.02.008
Interleukin-8 blockade prevents activated endothelial cell mediated proliferation and chemoresistance of acute myeloid leukemia.
来源期刊:Leukemia researchDOI:10.1016/j.leukres.2019.106180
Improving risk-stratification of patients with chronic lymphocytic leukemia using multivariate patient similarity networks.
来源期刊:Leukemia researchDOI:10.1016/j.leukres.2019.02.005
The value of FDP/FIB and D-dimer/FIB ratios in predicting high-risk APL-related thrombosis.
来源期刊:Leukemia researchDOI:10.1016/j.leukres.2019.02.007
Long noncoding RNA MIAT promotes the progression of acute myeloid leukemia by negatively regulating miR-495.
来源期刊:Leukemia researchDOI:10.1016/j.leukres.2019.106265
Low ferroportin expression in AML is correlated with good risk cytogenetics, improved outcomes and increased sensitivity to chemotherapy.
来源期刊:Leukemia researchDOI:10.1016/j.leukres.2019.02.011
Hepatic and cardiac and iron overload detected by T2* magnetic resonance (MRI) in patients with myelodisplastic syndrome: A cross-sectional study.
来源期刊:Leukemia researchDOI:10.1016/j.leukres.2018.12.001
Prospective observational study in comorbid patients with chronic lymphocytic leukemia receiving first-line bendamustine with rituximab.
来源期刊:Leukemia researchDOI:10.1016/j.leukres.2019.02.002
Relevant updates in systemic mastocytosis.
来源期刊:Leukemia researchDOI:10.1016/j.leukres.2019.04.001
Influence of donor KIR genotypes on reduced relapse risk in acute myelogenous leukemia after hematopoietic stem cell transplantation in patients with CMV reactivation.
来源期刊:Leukemia researchDOI:10.1016/j.leukres.2019.106230
A review of thrombotic microangiopathies in multiple myeloma.
来源期刊:Leukemia researchDOI:10.1016/j.leukres.2019.106195
Development of a novel fully-human anti-CD123 antibody to target acute myeloid leukemia.
来源期刊:Leukemia researchDOI:10.1016/j.leukres.2019.106178
Sequential azacitidine and lenalidomide for patients with relapsed and refractory acute myeloid leukemia: Clinical results and predictive modeling using computational analysis.
来源期刊:Leukemia researchDOI:10.1016/j.leukres.2019.04.005
Compound mutations involving T315I and P-loop mutations are the major components of multiple mutations detected in tyrosine kinase inhibitor resistant chronic myeloid leukemia.
来源期刊:Leukemia researchDOI:10.1016/j.leukres.2018.10.019
Ocular manifestations in acute lymphoblastic leukemia: A five-year cohort study of pediatric patients.
来源期刊:Leukemia researchDOI:10.1016/j.leukres.2018.11.017
The management and outcomes of patients with myelodysplastic syndrome with persistent severe thrombocytopenia: An observational single centre registry study.
来源期刊:Leukemia researchDOI:10.1016/j.leukres.2018.12.002
Predicting response to BET inhibitors using computational modeling: A BEAT AML project study
来源期刊:Leukemia researchDOI:10.1016/j.leukres.2018.11.010
Expression of platelet parameters and platelet membrane glycoproteins in childhood Burkitt lymphoma.
来源期刊:Leukemia researchDOI:10.1016/j.leukres.2019.106189
PRIMA-1MET cytotoxic effect correlates with p53 protein reduction in TP53-mutated chronic lymphocytic leukemia cells.
来源期刊:Leukemia researchDOI:10.1016/j.leukres.2019.106288
Pak1 gene functioned differentially in different BCR-ABL subtypes in leukemiagenesis and treatment response through STAT5 pathway.
来源期刊:Leukemia researchDOI:10.1016/j.leukres.2019.01.012
Comparison of frontline treatment with intensive immunosuppression therapy and HLA-haploidentical hematopoietic stem cell transplantation for young patients with severe aplastic anemia - A meta analysis.
来源期刊:Leukemia researchDOI:10.1016/j.leukres.2019.106266
Low-dose melphalan in elderly patients with relapsed or refractory acute myeloid leukemia: A well-tolerated and effective treatment after hypomethylating-agent failure.
来源期刊:Leukemia researchDOI:10.1016/j.leukres.2019.106192
Clinical presentation and prognosis of immunoglobulin light-chain amyloidosis with high percentage of bone marrow plasma cells.
来源期刊:Leukemia researchDOI:10.1016/j.leukres.2019.04.002
Comparison of therapy-related myelodysplastic syndrome with ring sideroblasts and de novo myelodysplastic syndrome with ring sideroblasts.
来源期刊:Leukemia researchDOI:10.1016/j.leukres.2019.106227
Tropolone-induced effects on the unfolded protein response pathway and apoptosis in multiple myeloma cells are dependent on iron.
来源期刊:Leukemia researchDOI:10.1016/j.leukres.2018.12.007
Expression analysis of genes located within the common deleted region of del(20q) in patients with myelodysplastic syndromes.
来源期刊:Leukemia researchDOI:10.1016/j.leukres.2019.106175
Complex karyotype as a predictor of high-risk chronic lymphocytic leukemia: A single center experience over 12 years.
来源期刊:Leukemia researchDOI:10.1016/j.leukres.2019.106218
Clinical and cost outcomes of pre-emptive plerixafor administration in patients with multiple myeloma undergoing stem cell mobilization.
来源期刊:Leukemia researchDOI:10.1016/j.leukres.2019.106215
Risk and outcomes of second malignant neoplasms in chronic myeloid leukemia survivors.
来源期刊:Leukemia researchDOI:10.1016/j.leukres.2019.05.004
Outcome of autologous hematopoietic stem cell transplant in older patients with B cell lymphoma when selected for fitness and chemosensitive disease.
来源期刊:Leukemia researchDOI:10.1016/j.leukres.2019.01.002
High RASD1 transcript levels at diagnosis predicted poor survival in adult B-cell acute lymphoblastic leukemia patients.
来源期刊:Leukemia researchDOI:10.1016/j.leukres.2019.03.005
Clinical presentation and prognostic analysis of Chinese patients with systemic light chain amyloidosis with liver involvement.
来源期刊:Leukemia researchDOI:10.1016/j.leukres.2019.106226
The role of high serum CXCL13 level in Waldenström macroglobulinemia.
来源期刊:Leukemia researchDOI:10.1016/j.leukres.2019.04.007
The upregulation of Pim kinases is essential in coordinating the survival, proliferation, and migration of KIT D816V-mutated neoplastic mast cells.
来源期刊:Leukemia researchDOI:10.1016/j.leukres.2019.106166
Gene expression profiling by mRNA sequencing reveals dysregulation of core genes in Rictor deficient T-ALL mouse model.
来源期刊:Leukemia researchDOI:10.1016/j.leukres.2019.106229
Replicative senescence of hematopoietic cells in patients with idiopathic cytopenia of undetermined significance.
来源期刊:Leukemia researchDOI:10.1016/j.leukres.2019.02.004
Additional prognostic impact of the percentage of erythroid cells in the bone marrow of patients with myelodysplastic syndromes.
来源期刊:Leukemia researchDOI:10.1016/j.leukres.2018.12.012
Prognostic gene alterations and clonal changes in childhood B-ALL.
来源期刊:Leukemia researchDOI:10.1016/j.leukres.2019.05.009
The relationship between clinical trial accrual volume and outcomes in acute myeloid leukemia: A SWOG/ECOG-ACRIN study (S0106 and E1900).
来源期刊:Leukemia researchDOI:10.1016/j.leukres.2019.01.007
Naquotinib exerts antitumor activity in activated B-cell-like diffuse large B-cell lymphoma.
来源期刊:Leukemia researchDOI:10.1016/j.leukres.2019.106286
High-dose etoposide and cyclophosphamide in adults and children with primary refractory and multiply relapsed acute leukaemias: The Royal Marsden experience.
来源期刊:Leukemia researchDOI:10.1016/j.leukres.2019.106217